Matcon News
AstraZeneca IPR operates
at OEL <1μg/m³
AstraZeneca is one of the world's leading pharmaceutical companies with a strong portfolio of drugs for treatment of cancer, cardiovascular, gastrointestinal, infection, neuroscience and respiratory conditions.
After extensive evaluation and testing, AstraZeneca selected the Matcon "Cone Valve" Intermediate Bulk Container system to handle the storage, movement and transfer of production batches across each step in the manufacturing process.
To read the entire case study please click the link below.
AstraZeneca Case Study
Back to news article listings
Adobe Acrobat Reader is required to view the case study.
Free download here.